HonCode

Go Back   HER2 Support Group Forums > her2group
Register Gallery FAQ Members List Calendar Search Today's Posts Mark Forums Read

Reply
 
Thread Tools Display Modes
Old 07-17-2018, 01:01 AM   #1
ariana
Senior Member
 
Join Date: Jun 2014
Posts: 159
Clinical trial results of tucatinib with T-DM1 shows promise in treating HER2+ breast

Clinical trial results of tucatinib with T-DM1 shows promise in treating HER2+ breast cancer.

Phase 1b clinical trial results published in*JAMA Oncology*show promise for the combination of tucatinib (formerly ONT-380) with T-DM1 against heavily pretreated HER2-positive breast cancer. Of 57 patients treated, 48 percent responded to the combination, with cancer control of median 8.2 months. Importantly, tucatinib acted against brain metastases stemming from HER2+ breast cancer, a major cause of mortality from the disease.

CLICK TO READ MORE:

https://www.news-medical.net/news/20...st-cancer.aspx

Last edited by ariana; 07-17-2018 at 01:03 AM.. Reason: mistake
ariana is offline   Reply With Quote
Reply

Tags
brain cancer, trial

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -7. The time now is 02:19 PM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2019, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007
free webpage hit counter